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Sialic  acids  (Sias)  are  monosaccharides  with   
a shared 9-carbon backbone, typically found   
at the terminal ends of vertebrate cell surface 
and secreted glycoconjugates (Schauer, 1982; 
Varki, 1992; Traving and Schauer, 1998; Angata 
and  Varki,  2002;  Chen  and  Varki,  2010).   
Most  mammals  express  two  common  Sias, 
N-acetylneuraminic  acid  (Neu5Ac)  and   
N-glycolylneuraminic acid (Neu5Gc). How-
ever, humans are deficient in Neu5Gc synthesis 
because of a human-specific mutation inactivat-
ing the CMAH gene responsible for converting 
CMP-Neu5Ac to CMP-Neu5Gc (Chou et al., 
1998; Irie et al., 1998). All human adults have 
varying levels of circulating IgM, IgG, and IgA 
antibodies  against  Neu5Gc  (Zhu  and  Hurst, 
2002; Tangvoranuntakul et al., 2003; Nguyen 
et  al.,  2005;  Padler-Karavani  et  al.,  2008; 
Tahara et al., 2010). At the same time, dietary 
Neu5Gc from foods such as red meat or milk 
products can be metabolically incorporated into 
human tissues, particularly epithelia and endothe-
lia (Tangvoranuntakul et al., 2003; Hedlund   
et al., 2007; Hedlund et al., 2008), through a 
mechanism involving macropinocytosis and   
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The nonhuman sialic acid N-glycolylneuraminic acid (Neu5Gc) is metabolically incorporated 
into human tissues from certain mammalian-derived foods, and this occurs in the face of 
an anti-Neu5Gc “xeno-autoantibody” response. Given evidence that this process contributes 
to chronic inflammation in some diseases, it is important to understand when and how 
these antibodies are generated in humans. We show here that human anti-Neu5Gc  
antibodies appear during infancy and correlate with weaning and exposure to dietary Neu5Gc. 
However, dietary Neu5Gc alone cannot elicit anti-Neu5Gc antibodies in mice with a  
humanlike Neu5Gc deficiency. Other postnatally appearing anti-carbohydrate antibodies 
are likely induced by bacteria expressing these epitopes; however, no microbe is known to 
synthesize Neu5Gc. Here, we show that trace exogenous Neu5Gc can be incorporated into 
cell surface lipooligosaccharides (LOS) of nontypeable Haemophilus influenzae (NTHi), a 
human-specific commensal/pathogen. Indeed, infant anti-Neu5Gc antibodies appear coincident 
with antibodies against NTHi. Furthermore, NTHi that express Neu5Gc-containing LOS 
induce anti-Neu5Gc antibodies in Neu5Gc-deficient mice, without added adjuvant. Finally, 
Neu5Gc from baby food is taken up and expressed by NTHi. As the flora residing in the 
nasopharynx of infants can be in contact with ingested food, we propose a novel model for 
how NTHi and dietary Neu5Gc cooperate to generate anti-Neu5Gc antibodies in humans.
© 2010 Taylor et al.  This article is distributed under the terms of an Attribution– 
Noncommercial–Share  Alike–No  Mirror  Sites  license  for  the  first  six  months   
after the publication date (see http://www.rupress.org/terms). After six months it 
is available under a Creative Commons License (Attribution–Noncommercial–Share 
Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/
by-nc-sa/3.0/).
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target epitope’s Neu5Gc side chain by mild periodate oxidation 
(Tangvoranuntakul et al., 2003), further demonstrating the 
specificity  of  the  IgG  antibodies  for  Neu5Gc-containing 
glycans (Fig. 1 C). The absence of anti-Neu5Gc IgM anti-
bodies in cord sera suggests that anti-Neu5Gc antibodies are 
not germ-line encoded “natural antibodies” (Ochsenbein 
and Zinkernagel, 2000), but instead require a postnatal anti-
genic stimulus. And the early appearance and class switching 
of these antibodies indicate that humans are exposed to the 
Neu5Gc antigenic stimulus early in life. The nadir in anti-
Neu5Gc IgG titer seen at 3 mo is also consistent with the 
half-life of maternally derived IgG (Morell et al., 1970), and 
suggests that these infants lack the production of endogenous 
anti-Neu5Gc IgG antibodies at 3 mo, when their diets were 
devoid of Neu5Gc. Interestingly, both infant IgM and IgG 
anti-Neu5Gc antibodies arise soon after the introduction of 
Neu5Gc in the diet in the form of cow’s milk formula and 
baby foods containing red meat.
Dietary Neu5Gc alone is insufficient to elicit anti-Neu5Gc 
antibodies in Neu5Gc-deficient mice
The temporal correlation between the appearance of anti-
Neu5Gc antibodies and the introduction of animal-derived 
foods suggested that dietary Neu5Gc might represent the anti-
genic stimulus. To study this issue experimentally, we used 
Cmah-null mice that have a human-like deficiency in Neu5Gc 
delivery of free Neu5Gc to the cytosol via a lysosomal trans-
porter (Bardor et al., 2005; Yin et al., 2006). Evidently, although 
the human immune system can react to this xeno-antigen, 
human biochemical pathways do not see it as foreign. Thus, 
anti-Neu5Gc antibodies represent novel “xeno-autoantibodies,” 
which recognize a “non-self” animal-derived antigen in the 
context of “self.” Indeed, we have recently demonstrated that 
human anti-Neu5Gc antibodies interact with metabolically 
incorporated Neu5Gc to promote chronic inflammation, 
likely contributing to tumor progression (Hedlund et al., 2008) 
and vascular inflammation (Pham et al., 2009).
Given their potential contribution to the pathogenesis of 
dietary red meat–associated diseases, it is important to under-
stand when and how anti-Neu5Gc antibodies emerge in   
humans. Here, we show that these antibodies emerge post-
natally in humans during the first year of life. Other post-
natally acquired human antibodies against foreign glycans, 
e.g., blood group antibodies and anti–-Gal antibodies, are 
thought to be induced by commensal bacteria expressing 
these epitopes (Springer and Horton, 1969; Galili et al., 
1988). However, although many bacteria can synthesize and 
express Neu5Ac (Vimr and Lichtensteiger, 2002; Vimr et al., 
2004), none are known to synthesize Neu5Gc. Here, we 
demonstrate that dietary Neu5Gc can be incorporated by a 
common human commensal bacterium, providing a mecha-
nism for generating anti-Neu5Gc antibodies during the first 
year of life. To our knowledge, this is the first example in 
which  a  diet-derived  molecule  is  scavenged  by  resident   
bacteria from within the host and effectively expressed as an   
immunogenic antigen.
RESULTS
Human anti-Neu5Gc antibodies appear during  
the first year of life and correlate with the introduction  
of Neu5Gc in the diet
Sera from infants age 0–12 mo (cord, 3 mo, 6 mo, and 12 mo) 
were analyzed by ELISA for the presence of anti-Neu5Gc 
IgM and IgG antibodies against Neu5Gc2–6Gal1–4Glc 
(Gc2–6Lac), an epitope against which most human adults 
possess high levels of IgM and IgG antibodies (Padler-Karavani 
et al., 2008). All sera were from infants who had been exclu-
sively breastfed for the first 3 mo of life, and then switched to 
cow’s milk–based formula. Solid foods were also introduced 
starting  at  3  mo  of  age  and  included  both  foods  lacking 
Neu5Gc,  such  as  fruits  and  vegetables,  and  Neu5Gc-rich 
foods, such as beef, pork, and lamb. Anti-Neu5Gc IgM anti-
bodies were absent at birth (cord serum) and at 3 mo, appeared 
at 6 mo and achieved almost adult levels at 12 mo (Fig. 1 A). 
As expected because of transplacental transport of IgG, all 
cord sera contained anti-Neu5Gc IgG antibodies, at levels 
similar to maternal anti-Neu5Gc IgG. These anti-Neu5Gc 
IgG antibodies diminished at 3 mo, followed by increasing 
levels at 6 and 12 mo (Fig. 1 B). There was no difference   
between male and female anti-Neu5Gc IgM and IgG titers 
(unpublished data). The reactivity of 12 mo sera against 
Gc2–6Lac was significantly reduced after truncation of the 
Figure 1.  Anti-Neu5Gc antibodies in human infants. (A and B) Levels 
of anti-Neu5Gc IgM (A) and IgG (B) antibodies in infant sera (n = 15, filled 
circles) from birth (cord), 3, 6, at 12 mo (for each infant) and adult sera 
from the pregnant mothers (n = 9, open squares) were measured by ELISA 
against Neu5Gc2–6Lac–HSA. Each data point represents the mean of 
triplicate values from one individual, quantified according to an IgM or 
IgG standard curve. Horizontal lines represent mean values for each 
group. (C) Neu5Gc2–6Lac–HSA coated on an ELISA plate was treated 
with mild periodate (periodate) or inactivated periodate (mock periodate), 
and then analyzed for binding by IgG antibodies from infants at 12 mo of 
age (n = 15). Bars represent mean absorbance values at OD490 ± SEM. 
Statistical analysis was performed using an unpaired two-tailed Student’s 
t test. (D) Infant sera (same infants as in A and B) were analyzed by ELISA 
for IgM antibodies against -Gal-PAA (dashed line). For comparison, anti-
-Gal IgM levels were plotted with anti-Neu5Gc IgM levels (solid line; 
same data as in Fig. 1 A). Values represent mean IgM levels ± SEM.JEM VOL. 207, August 2, 2010 
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unsuccessful to date. These include: providing free Neu5Gc in 
the drinking water at 1 mg/ml for 12 wk; cross-fostering Cmah-
null pups with WT dams whose milk contains Neu5Gc (simulat-
ing cow’s milk-based formula feeding in human infants); feeding 
with high-Neu5Gc content mucins; feeding with Neu5Gc-rich 
goat cheese; and oral gavage with cow’s milk (unpublished data; 
see Table I for details). These negative results are also interesting 
because Cmah-null mice actually have relatively hyper-reactive   
B cells, apparently caused by loss of Neu5Gc-containing Siglec 
ligands (Naito et al., 2007; Cariappa et al., 2009).
In contrast, deliberate immunization with an artificial im-
munogen rich in Neu5Gc, such as chimpanzee RBCs, and 
complete Freund’s adjuvant, did elicit anti-Neu5Gc IgM and 
IgG antibodies in Cmah-null, but not WT, mice (Hedlund et al., 
2008). Thus, despite the lack of spontaneously generated anti-
Neu5Gc antibodies, Cmah-null mice are capable of generating a 
humoral immune response against Neu5Gc upon active immu-
nization (Fig. 2, A and B). Recently, another group also reported 
that a different strain of Cmah-null mice do not spontane-
ously express anti-Neu5Gc antibodies, and require artificial im-
munization to generate a humoral immune response (Tahara   
et al., 2010).
Trace amounts of Neu5Gc are taken up and expressed  
on LOS of NTHi, a human-specific commensal/pathogen
Some other postnatally appearing anticarbohydrate antibodies 
in humans, such as anti–-Gal and antiblood group anti-
bodies, have been shown to be elicited in response to resident 
gut bacteria expressing these epitopes (Springer and Horton, 
1969; Galili et al., 1988; Posekany et al., 2002). Interestingly, 
we found that the appearance of anti-Neu5Gc antibodies   
in human infant sera coincides with the appearance of both 
anti–-Gal (Fig. 1 D) and anti-blood group antibodies (not 
depicted), suggesting that anti-Neu5Gc antibodies may also 
be elicited by colonizing bacteria during infancy. In this regard, 
many human microbial pathogens/commensals express Sias 
on their surface glycans, creating a resemblance to “self”   
glycoproteins  and  glycolipids  found  in  mammals  (Vimr 
and Lichtensteiger, 2002; Vimr et al., 2004; Lewis et al., 
2009). This molecular mimicry of host glycans can help 
synthesis (Hedlund et al., 2007). However, despite consump-
tion of 1 mg/kg/day of Neu5Gc in their regular chow 
(unpublished data; this represents approximately five times 
the  amount  present  in  the  typical  human  Western  diet; 
Tangvoranuntakul  et  al.,  2003),  Cmah-null  mice  did  not 
spontaneously generate anti-Neu5Gc IgM or IgG antibodies 
after 6–9 mo (Fig. 2, A and B). In fact, as summarized in   
Table I, all attempts to induce anti-Neu5Gc antibodies in 
Cmah-null mice via dietary Neu5Gc exposure have been   
Figure 2.  Dietary Neu5Gc does not elicit anti-Neu5Gc antibodies. 
(A and B) WT (open bars, n = 8) and Cmah/ (filled bars, n = 8) were  
fed 1 mg/kg/day Neu5Gc (from normal chow) after weaning (4–6 wk 
total), immunized with human RBC ghosts (WT, n = 4; Cmah/, n = 4),  
or immunized with chimpanzee RBC ghosts (WT, n = 4; Cmah/,  
n = 4). Sera were analyzed by ELISA for IgM (A; note the broken y axis) and  
IgG (B) antibodies against Neu5Gc-PAA and shown as mean absor-
bance values at OD405 ± SEM. Statistical analysis was performed  
using an unpaired two-tailed Student’s t test. n.s, not significant,  
*, P < 0.05; **, P < 0.01. Data are representative of greater than three  
independent experiments.
Table I.  Unsuccessful attempts at generating anti-Neu5Gc antibodies in Neu5Gc-deficient mice
Unsuccessful attempt Data/comments
Feeding regular mouse chow Normal mouse chow diet provides 1 mg/kg/day Neu5Gc (>5 times the amount found in 
Western diets; Tangvoranuntakul et al., 2003).
Adding free Neu5Gc to drinking water Maximum exposure 1 mg/ml in drinking water for 12 wk.
Feeding cow’s milk Cow’s milk contains 8 µg/g total Neu5Gc (Tangvoranuntakul et al., 2003). Gavaged 250 µl  
5 d/wk for 4 wk.
Feeding goat cheese Rich in Neu5Gc-containing glycolipids, 39.9 µg/g total Neu5Gc (Tangvoranuntakul et al., 2003)
Feeding mucin Very rich in Neu5Gc. Mixed in with regular mouse chow.
Breastfeeding/fostering by WT females WT mouse breast milk contains Neu5Gc. Simulates infant exposure to cow’s milk or cow’s milk-
based formula.
In utero exposure of Cmah-null pups to Neu5Gc 
positive Cmah+/ mother
Cmah-null mice born loaded with Neu5Gc, which clears within weeks. Simulates infant/fetal 
exposure to Neu5Gc through the mother’s diet.1640 Commensal flora in human xeno-autoantibody induction | Taylor et al.
(Fig. 3 B). Finally, no Neu5Gc expression was seen in NTHi 
strain 2019siaT (Allen et al., 2005), an isogenic mutant that 
lacks a critical Sia transporter (see Fig. 6 A, top left). Collectively, 
our data indicate that dietary Neu5Gc may be efficiently taken 
up and then expressed on cell surface molecules of NTHi.
Infant antibodies against Neu5Gc-glycans appear coincident 
with the appearance of antibodies against NTHi
Most humans are colonized by NTHi (Turk, 1984). We next 
asked whether there was a temporal correlation between the 
timing of initial NTHi colonization or infection and the ap-
pearance of anti-Neu5Gc antibodies. As neither nasopharyn-
geal nor middle ear cultures were available from the infants in 
our cohort, we used a whole-cell ELISA to screen for anti-
bodies against NTHi as an indicator of colonization or infec-
tion. For these studies, NTHi was grown in Sia-free defined 
media to ensure absence of Neu5Gc on the LOS of the bac-
teria. In all infants analyzed, we could detect IgM antibodies 
pathogens evade, dampen, and/or inhibit host immune de-
fenses (Estabrook et al., 1997; Ram et al., 1998; Carlin et al., 
2009). Several bacterial species, including Escherichia coli K1, 
Campylobacter jejuni, most meningococcal strains, and Strepto­
coccus agalactiae are able to synthesize Sia de novo (Vimr and   
Lichtensteiger, 2002). However, the parent Sia structure is always 
Neu5Ac, and no microbe has ever been shown to synthesize 
Neu5Gc. Indeed, the biosynthesis of the N-glycolyl group of 
Neu5Gc appears to be a singular event in evolution, being con-
fined to the Deuterostome lineage of animals (Schauer, 1982).
On the other hand, certain sialylated bacteria including 
Neisseria gonorrhoeae, Haemophilus influenzae, Haemophilus ducreyi, 
and Corynebacterium diphtheriae lack the biosynthetic machin-
ery necessary for Sia synthesis and instead scavenge host-derived 
Sias  (Mandrell  et  al.,  1990;  Mattos-Guaraldi  et  al.,  1998; 
Schilling et al., 2001; Bouchet et al., 2003). Non-typeable   
H. influenzae (NTHi) colonizes most humans and can transi-
tion from a commensal to a pathogenic state in diseases such 
as infantile otitis media. NTHi can efficiently scavenge minute 
amounts of environmental free Sias via a specific transporter 
(Allen et al., 2005; Severi et al., 2005), and then use an en-
dogenous CMP-Sia synthetase (Hood et al., 1999) and sialyl-
transferases (Jones et al., 2002) to decorate its LOS. These 
sialylated LOS molecules are critical for NTHi human serum 
resistance (Hood et al., 1999; Allen et al., 2005) and viru-
lence in a chinchilla otitis media model (Bouchet et al., 2003; 
Jurcisek et al., 2005).
Of the aforementioned bacteria, only H. influenzae has 
the potential to access dietary Neu5Gc while living as part of 
the human flora. We hypothesized that NTHi might scavenge 
exogenous dietary Neu5Gc and express it as an immunogenic 
epitope, providing a mechanism for the generation of anti-
Neu5Gc antibodies in human infants. To pursue this hypoth-
esis, we grew the NTHi strain 2019 (Campagnari et al., 1987) 
in a Sia-free defined medium and analyzed the bacteria by 
flow cytometry using a Neu5Gc-specific chicken IgY anti-
body (Diaz et al., 2009). When 2019 was grown in Sia-free 
defined media, the anti-Neu5Gc antibody background stain-
ing was similar to the control IgY, confirming the inability of 
NTHi to synthesize endogenous Neu5Gc (Fig. 3 A). However, 
when exogenous free Neu5Gc (0.1 µM–1 mM) was added to 
the defined media, there was a dose-dependent increase in 
anti-Neu5Gc binding, again, compared with no binding by 
the control IgY antibody (Fig. 3 A). Similar results were found 
(unpublished data) using two other NTHi strains, Int1 (Nizet 
et al., 1996) and DH1 (Houliston et al., 2007), as well as one 
encapsulated type b strain, Eagan (Anderson et al., 1972). 
Thus, uptake and surface expression Neu5Gc is a common 
feature among different strains of H. influenzae.
To  further  confirm  Neu5Gc  incorporation  by  NTHi, 
2019 was grown in 1 mM Neu5Gc, treated with sialidase or 
heat-inactivated sialidase, and then probed in a whole-cell 
ELISA  with  the  chicken  anti-Neu5Gc  antibody.  Sialidase 
treatment decreased anti-Neu5Gc staining when compared 
with treatment with heat-inactivated sialidase, demonstrating 
release of Neu5Gc from NTHi surface glycans by active sialidase 
Figure 3.  NTHi can efficiently take up and incorporate Neu5Gc. 
(A) Dose-dependent uptake and expression of NTHi (2019) grown in a  
Sia-free defined media with 0.1 µM–1 mM Neu5Gc. Neu5Gc was detected 
by flow cytometry analysis using a chicken anti-Neu5Gc IgY antibody.  
(B) 2019 grown in 1 mM Neu5Gc were treated with sialidase (sialidase) or 
heat-inactivated sialidase (mock sialidase) and probed with a chicken 
anti-Neu5Gc IgY antibody in a whole-cell ELISA. Data are representative 
of greater than three independent experiments and show the mean of 
triplicate absorbance values at OD405. Error bars represent SD.JEM VOL. 207, August 2, 2010 
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elicit anti-Neu5Gc antibodies in Cmah-null mice via intra-
nasal administration of Neu5Gc-expressing NTHi have been 
unsuccessful (unpublished data). This is not surprising, given 
that mice show very rapid mucosal clearance of this human-
specific microorganism and limited nasopharyngeal coloniza-
tion (Zola et al., 2009). Furthermore, human infants are prone 
to major upper respiratory infections with NTHi, and the 
immune  response  we  are  studying  would  likely  be  en-
hanced by such inflammation in infants. The anti-Neu5Gc 
IgG antibodies generated in Cmah-null mice were also tested 
for reactivity against different Neu5Gc containing antigens 
and found to be of similar titer and specificity to those we 
have found in human infants (Fig. 5 C) and adults (Padler-
Karavani et al., 2008).
against NTHi that increased significantly between birth, 3, 6, 
and 12 mo (Fig. 4). Because it is unlikely that all infants in 
our cohort have had NHTi otitis media by 3 mo of age, it is 
likely that these increased titers of antibody against whole-cell 
NTHi are a response to NTHi colonization. These results are 
consistent with those of others who have shown that most 
infants acquire NTHi within the first year of life (Vives et al., 
1997), and that infants generate antibodies against outer mem-
brane proteins on NTHi during the course of asymptomatic 
colonization (Faden, 2001). Thus, infants in our cohort gener-
ated an adaptive immune response against colonizing NTHi 
at about the same time that anti-Neu5Gc antibodies appear.
NTHi with Neu5Gc-containing LOS can induce IgM and IgG 
anti-Neu5Gc antibodies in Neu5Gc-deficient mice
Given the temporal relationship between the appearance of 
anti-Neu5Gc antibodies and colonization with NTHi, we 
next asked whether Neu5Gc-expressing NTHi could elicit 
an anti-Neu5Gc antibody response in Neu5Gc-deficient mice, 
which did not spontaneously express anti-Neu5Gc antibodies 
(Table I). To this end, Cmah-null mice were injected intra-
peritoneally with heat-killed NTHi, which had been grown 
in  Sia-free  media  with  Neu5Gc  (generating  Neu5Gc  ex-
pressing NTHi, Gc-NTHi) or without Neu5Gc (generating 
Sia-free NTHi, Sia-free NTHi). To assess the inherent im-
munogenicity of the Gc-NTHi, no adjuvant was used to en-
hance antibody responses. Sia-free NTHi represents an ideal 
negative control because, except for the absence of Neu5Gc, 
it is identical to Gc-NTHi. Indeed, only Cmah-null mice   
injected with Gc-NTHi generated anti-Neu5Gc IgM anti-
bodies and underwent class switching to generate IgG anti-
bodies after 2–3 injections (Fig. 5, A and B). In contrast, 
Cmah-null mice injected with Sia-free NTHi did not generate 
anti-Neu5Gc antibodies (Fig. 5, A and B). Multiple attempts to 
Figure 4.  Anti-NTHi antibodies in human infants. Infant sera (same 
infants analyzed in Fig. 1; n = 15) were analyzed by whole-cell ELISA for 
IgM antibodies against NTHi strain 2019 grown in Sia-free media (filled 
circles). Adult sera (n = 9) obtained from the pregnant mothers of the 
infants in this study were analyzed in parallel with infant sera for IgM 
anti-NTHi antibodies (open squares). Each circle or square represents the 
mean of triplicate values from one individual, quantified according to an 
IgM standard curve. Horizontal lines represent mean values for each 
group. Statistical analysis was performed using an unpaired two-tailed 
Student’s t test.
Figure 5.  Neu5Gc expressed on NTHi induces anti-Neu5Gc  
antibodies in Cmah/ mice. (A and B) Cmah/ mice were injected 
intraperitoneally with heat-killed NTHi (without adjuvant) which had been 
grown in sialic-acid free media (Sia-free NTHi, n = 16) or with sialic-acid 
free media with 1 mM Neu5Gc (Gc-NTHi, n = 17). All mice were injected  
a total of three times at 2-wk intervals. Sera collected after the third  
injection were analyzed by ELISA for IgM (A) and IgG (B) antibodies 
against Neu5Gc-PAA. The highest and lowest value from each group 
was removed before graphing. Horizontal lines represent the mean values. 
Statistical analysis was performed using an unpaired one-tailed Student’s 
t test. (C) Pooled mouse serum from mice injected intraperitoneally with 
heat-killed NTHi grown in sialic-acid free media with 1 mM Neu5Gc was 
analyzed in an ELISA for levels of anti-Neu5Gc IgG antibodies against 
Neu5Gc2–3Gal1–4Glc-HSA (black bar), Neu5Gc2–6Gal1–4Glc-HSA 
(gray bar), Neu5Gc2–3Gal1–4GlcNAc-HSA (white hashed bar), and 
Neu5Gc2-6Gal1-4GlcNAc-HSA (white bar). Values represent mean  
IgG levels, quantified according to a mouse IgG standard curve. Error bars 
represent SD. For comparison, serum from 12-mo-old infants (n = 15) 
was analyzed for levels of anti-Neu5Gc antibodies against Neu5Gc2–
3Gal1–4Glc-HSA (black bar), Neu5Gc2–6Gal1–4Glc-HSA  
(gray bar; same data as shown in Fig. 1 B). Values represent mean  
IgG levels, quantified according to a human IgG standard curve. Error  
bars represent SEM. Data are representative of greater than three inde-
pendent experiments.1642 Commensal flora in human xeno-autoantibody induction | Taylor et al.
foods consisting of red meat (beef, pork, and lamb) but not in 
poultry (chicken and turkey; unpublished data), vegetables or 
fruits. In contrast, there was no Neu5Gc expression seen in 
the siaT mutant of 2019, confirming that uptake through the 
Sia transporter is required for expression of dietary Neu5G by 
NTHi. Furthermore, an even greater shift in anti-Neu5Gc 
staining (an approximately fourfold increase in MFI compared 
with WT) was seen with a NTHi sialic acid lyase-deficient 
mutant (2019nanA; unpublished data), which develops a hyper-
sialylated phenotype in the presence of exogenous Sia (Allen 
et al., 2005). The finding that Neu5Gc expression by NTHi 
was restricted to uptake from baby foods containing red meat is 
not surprising, as red meat is known to contain high levels of 
Neu5Gc, whereas poultry contains only Neu5Ac and plants 
contain no Sia (Tangvoranuntakul et al., 2003). NTHi do not 
produce a sialidase (Vimr and Lichtensteiger, 2002), and there-
fore require free (nonglycosidically bound) Sia for LOS si-
alylation. Indeed, when Sia levels were quantified in the baby 
food, considerable levels of free Neu5Gc (2 µg/g; Table II) 
were detected in baby food containing red meat, but not in 
those containing poultry or plants (Table II). Of course, many 
other oral and nasopharyngeal commensal bacteria express siali-
dases (Corfield, 1992), which could further increase the local 
concentrations of free Neu5Gc for use by NTHi in vivo.
Purified human anti-Neu5Gc antibodies specifically 
recognize Neu5Gc-expressing NTHi
To further corroborate our hypothesis, we asked if anti-
Neu5Gc antibodies that were affinity purified from normal 
human serum (Padler-Karavani et al., 2008) could interact 
with Neu5Gc-expressing NTHi in a whole-cell ELISA.   
Indeed, human anti-Neu5Gc antibodies bound specifically to 
Neu5Gc-expressing NTHi (Gc-NTHi) and not to nonsi-
alylated NTHi (Sia-Free NTHi; Fig. 6 B).
DISCUSSION
In this study, we propose a model for how NTHi and dietary 
Neu5Gc cooperate to generate anti-Neu5Gc antibodies in 
humans. Collectively, our data indicate a mechanism by which 
humans may generate anti-Neu5Gc antibodies in early life, 
by simultaneous exposure to Neu5Gc-containing foods and 
the incorporation and surface expression of the nonhuman 
Sia by colonizing NTHi. As a Gram-negative bacterium that 
expresses pathogen-associated molecular patterns such as LPS, 
this Neu5Gc-expressing organism would simultaneously pro-
vide both immunogen and adjuvant. It is also interesting that 
NTHi can scavenge and express Neu5Gc from  
Neu5Gc-Containing Foods
NTHi that are colonizing the infant’s oropharynx and even 
upper airways can have direct access to dietary Neu5Gc, since 
reflux of ingested liquids into the infant upper respiratory 
tract is commonly observed (Cober and Johnson, 2005). To 
determine if NTHi can take up and express Neu5Gc from 
baby food, NTHi was grown in Sia-free media with or with-
out various commercially available semi-solid baby foods and 
analyzed by flow cytometry for cell-surface Neu5Gc. As 
shown in Fig. 6 A, WT NTHi strain 2019 (WT) was found 
to express Neu5Gc when grown in the presence of baby 
Figure 6.  NTHi uptake and expression of Neu5Gc from baby food 
and its recognition by purified human anti-Neu5Gc antibodies.  
(A) WT NTHi strain 2019 (WT, solid line) and Sia transporter mutant strain 
of 2019 (SiaT Mutant, dashed line) were grown in Sia-free media with or 
without the addition of commercially available baby foods and analyzed 
by flow cytometry for Neu5Gc staining using the chicken anti-Neu5Gc 
IgY antibody. Secondary antibody for WT and SiaT Mutant (not depicted) 
and IgY control for SiaT Mutant (not depicted) all showed similar shifts 
compared with the IgY control for WT (solid gray). (B) Anti-Neu5Gc IgG 
antibodies purified from serum from a single individual (S34) was used to 
probe NTHi in a whole-cell ELISA. NTHi was grown in Sia-free media  
(Sia-Free NTHi) or Sia-free media with 1 mM Neu5Gc (Gc-NTHi), and 
binding of human antibodies is shown the mean of triplicate values at 
OD405. Error bars represent SD. Statistical analysis was performed using an 
unpaired two-tailed Student’s t test. ***, P < 0.0001. Data are representative 
of two (A) and three (B) independent experiments.
Table II.  Quantification of Neu5Gc in commercial baby food
Baby foods Red meat Poultry
Beef (n = 2) Lamb (n = 1) Ham (n = 1) Chicken (n = 2) Turkey (n = 2)
Total Neu5Gca g/g 10.19 5.40 5.13 <0.07 <0.07
Free Neu5Gca g/g 2.68 1.56 0.98 <0.03 <0.03
aTotal and free (non-glycosidically bound) Neu5Gc in commercial baby foods was determined by DMB-HPLC as described in Materials and methods. Data represent average 
values from two independent experiments. Previous studies have shown that plants are devoid of sialic acids (Zeleny et al., 2006).JEM VOL. 207, August 2, 2010 
Article
1643
times in sialic acid–free media: RPMI 1640 media (Sigma-Aldrich) supple-
mented with 1 µg/ml protoporphyrin IX (Sigma-Aldrich), 1 µg/ml l-histidine 
(Sigma-Aldrich), 10 µg/ml -nicotinamide adenine dinucleotide (Sigma-
Aldrich), 0.1 mg/ml hypoxanthine (Sigma-Aldrich), 0.1 mg/ml uracil (Sigma-
Aldrich), and 0.8 mM sodium pyruvate (Invitrogen; Greiner et al., 2004; 
Allen et al., 2005). The absence of sialic acid was confirmed by HPLC and mass 
spectrometry. Commercial baby foods from Gerber Product Company and 
Beech-Nut Nutrition Company were purchased at a local grocery store.
Neu5Gc uptake by NTHi. NTHi strain 2019 or 2019siaT grown to mid-
log (OD600 0.30.4) in sialic acid–free media, was grown for 2 h with or 
without various amounts of Neu5Gc (Inalco), washed twice with PBS, and 
then incubated for 1 h at RT with chicken anti-Neu5Gc IgY (1:2,000; Diaz 
et al., 2009), control chicken IgY (1:2,000; Jackson ImmunoResearch Labo-
ratories), or PBS alone. After washing once with PBS, bacteria were resuspended 
in  FITC  donkey  anti–chicken  antibody  (1:200;  Jackson  ImmunoResearch 
Laboratories) for 1 h at room temperature and analyzed by flow cytometry 
(FACSCalibur; BD). For uptake of Neu5Gc from baby food, each food was 
diluted with an equal volume of sialic acid–free media and the particulate 
matter pelleted by centrifugation. After filter sterilization, the filtrate was 
added to an equal volume of mid-log bacteria in sialic acid–free media, un-
derwent incubated shaking (250 RPM) for 2 h at 37°C, washed twice with 
PBS, and stained for Neu5Gc by flow cytometry, as described above. Siali-
dase treatment after Neu5Gc loading of NTHi was performed by resuspend-
ing 500 µl (OD600 0.4) in 150 µl PBS, pH 6.0 + 9 mM CaCl2 with 10 mU 
active or heat-inactivated (10 min at 100°C) Vibrio cholerae sialidase (Sigma-
Aldrich) for 3 h at 37°C. Neu5Gc was detected in a whole-cell ELISA by 
resuspending the bacteria in Milli-Q water, adding to a 96-well plate (Corn-
ing), and evaporating overnight. Wells were washed with Tris-buffered sa-
line, pH 7.4, + 0.1% Tween (TBST), and then incubated with chicken 
anti-Neu5Gc IgY (1:1,000), isotype control chicken IgY (1:1,000), or TBST 
alone for 1 h at room temperature, 100 µl/well. Wells were then washed 
three times with 150 µl TBST, incubated with 100 µl/well alkaline phospha-
tase  (AP)  donkey  anti–chicken  IgY  (1:5,000;  Jackson  ImmunoResearch 
Laboratories) for 1 h at room temperature, washed as before, and then devel-
oped with p-nitrophenyl phosphate, with product measured at 405-nm 
wavelength on a SpectraMax 250 (MDS Analytical Technologies).
Generation of anti-Neu5Gc antibodies in mice. NTHi strain 2019 was 
grown to mid-log in sialic acid–free media with or without 1 mM Neu5Gc 
(Inalco), heat-killed, and injected (200 µl of OD600 0.4) intraperitoneally into 
Cmah-null and WT (C57BL/6) mice (age 58 wk, female). All mice were 
injected a total of three times at 2-wk intervals. No adjuvant was used with 
any of the bacterial injections. Erythrocyte immunizations were performed 
as described previously (Hedlund et al., 2008). In brief, Cmah-null mice (age 
69 wk, male and female) were injected intraperitoneally with 200 µg 
chimpanzee (Neu5Gc-rich; Yerkes National Primate Research Center, Emory 
University,  Emory,  GA)  or  human  (Neu5Gc-free)  erythrocyte  mem-
brane ghosts in 100 µl PBS with equal volume Freund’s complete adjuvant 
(Difco), and boosted twice (2 and 8 wk later) with the same amount of im-
munogen in Freund’s incomplete adjuvant (Difco). Serum for antibody 
analysis was collected 7 d after the second boost.
Detection  of  mouse  anti-Neu5Gc  antibodies.  Mouse  sera  were   
analyzed for anti-Neu5Gc antibodies against Neu5Gc-PAA (Glycotech) by 
ELISA, as previously described (Hedlund et al., 2008). In brief, 96-well 
plates (Costar 9018; Corning) were coated overnight at 4°C with 250 ng/well 
Neu5Gc-PAA in 50 mM sodium carbonate-bicarbonate buffer, pH 9.5. 
Wells were emptied of coating solution and blocked with 200 µl/well   
TBS + 0.1% Tween, pH 7.4 (TBST) for 2 h at room temperature. Sera were 
added to the wells for 2 h at room temperature in triplicate, diluted 1:200 in 
100 µl TBST. After washing three times with 150 µl TBST, wells were in-
cubated with 100 µl alkaline phosphatase-conjugated goat anti–mouse IgM 
(Calbiochem) or IgG (Jackson ImmunoResearch Laboratories), diluted 
1:5,000 in TBST for 1 h at RT. Wells were washed again, as described,   
this carbohydrate antigen elicits class switching to generate 
sometimes high levels of IgG antibodies. In this regard, direct 
engagement of LPS with TLR4 on B cells of mice is known 
to promote proliferation, class switching, and immunoglobu-
lin secretion (Peng, 2005). Furthermore, LPS-induced secretion 
of BAFF and APRIL by dendritic cells and monocytes could 
contribute to T cell–independent induction of class switch 
recombination (Fagarasan and Honjo, 2000; Litinskiy et al., 
2002), especially in the setting of inflammation (Ueda et al., 
2007) that is commonly associated with NTHi-mediated oti-
tis media. Future studies of mice and humans with various 
genetically defined immunodeficiencies should help to define 
the cellular and molecular pathways required for the genera-
tion of anti-Neu5Gc antibodies, and address the question of 
T cell dependence versus independence, and the role of Toll-
like receptors. Identifying the specific B cell populations that 
produce anti-Neu5Gc antibodies and determining if these   
B cells undergo somatic hypermutation will also help to char-
acterize the anti-Neu5Gc response in humans and mice. An 
additional contributing factor may be the relative overreac-
tivity of human B cells to stimulation (Soto et al., 2010).
We have shown here that NTHi is capable of scavenging 
Neu5Gc from the diet and expressing it as an immunogenic 
epitope, apparently contributing to the generation of anti-
Neu5Gc antibodies in humans. Thus, our normal flora can 
act as “antigen-presenting cells” of bacterial rather than host 
origin, eliciting humoral immune responses that could con-
tribute to inflammatory or autoimmune pathologies. Although 
NTHi is the first known commensal shown to express scav-
enged dietary Neu5Gc, it is possible that other as yet unknown 
commensal/pathogenic bacteria can do the same. In this re-
gard, the wide variation in adult human anti-Neu5Gc titers 
and specificity between adult individuals (Padler-Karavani et al., 
2008) may reflect multiple routes of xeno-autoimmunization.
MATERIALS AND METHODS
Mice. Cmah/ mice (Hedlund et al., 2007) were backcrossed onto a con-
genic  C57BL/6  background.  WT  C57BL/6  mice  were  purchased  from 
Harlan Laboratories. Mice were fed standard chow (PicoLab Rodent Diet 20; 
LabDiet) and water ad libitum and maintained on a 12-h light/dark cycle. 
All animal work was performed in accordance with The Association for   
Assessment and Accreditation of Laboratory Animal Care and under a pro-
tocol approved by the Institutional Animal Care and Use Committee of the 
University of California, San Diego, La Jolla, CA.
Human serum samples. Collection of maternal and infant blood samples 
for immunological studies was approved by the University of La Frontera, 
Temuco, Chile, Institutional Review Board and approved by the Regional 
Ethical Committee of the Chilean National Health Service for the Araucania 
Region in which the samples were collected. Written informed consent for 
study of infants was obtained from both parents. Serum was collected from 
15 Chilean infants at birth (from cord blood), 3, 6, and 12 mo of age. Serum 
from 9 of the 15 mothers in the study was obtained during the third trimester 
of pregnancy, with consent.
Bacteria, growth conditions, and baby food. NTHi strains 2019   
(Campagnari et al., 1987) and 2019siaT (Allen et al., 2005) were a generous 
gift  from  Michael  Apicella,  Department  of  Microbiology,  University  of 
Iowa. Sialic acid–free bacterial stocks were prepared by passaging 2019 several 1644 Commensal flora in human xeno-autoantibody induction | Taylor et al.
Quantification of Neu5Gc in commercial baby foods. For analysis of 
nonglycosidically bound (free) Neu5Gc in baby food, 50 mg of each baby 
food was resuspended in 200 µl Milli-Q water (for analysis of total Neu5Gc, 
samples were heated to 80°C in 2 M acetic acid for 3 h to release sialic acids) 
and centrifuged at 10,000 g for 10 min at 4°C. The supernatant was then fil-
tered through a 10,000 molecular weight cutoff filter, and sialic acids in the 
filtrate were derivatized with 1,2-diamino-4,5-methylenedioxybenzene (DMB; 
Sigma-Aldrich) as described previously (Manzi et al., 1990) and analyzed by   
reverse-phase HPLC using a C18 column (Phenomenex) at a flow rate of   
0.9 ml/min, using 88% water, 5% acetonitrile, and 7% methanol. The excitation 
and emission were at 373 and 448 nm, respectively. The DMB-derivatized 
sialic acids were identified and quantified by comparing elution times and 
peak areas to known standards.
Statistics. Statistical analysis was performed using Prism v5.0a (GraphPad 
Software).
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